FDA to expand use of remote regulatory assessments beyond the pandemic

The Food and Drug Administration plans to expand its use of remote regulatory assessments. In a Friday guidance, the agency concluded that the assessments should be used for certain scenarios outside the current pandemic and for all types of FDA-regulated products.